Global Opioids Drugs Market Research Report 2024, Forecast to 2029
- Report Code : MUL2758405
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 162
-
Opioids are a class of drugs naturally found in the opium poppy plant and that work in the brain to produce a variety of effects
Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.
We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.
The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.
We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.
The report will conduct a comprehensive and professional analysis of the Opioids Drugs market in 2024 based on the current situation, global economic impact and other aspects.
Market Segment by Product Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market Segment by Product Application
Pain Relief
Anesthesia
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm
Insights and Tools:
This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.
The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.
Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To define, describe and forecast the Opioids Drugs market by type, application, end user and region
2.Provide enterprise external environment analysis and SWOT analysis
3.Focuses on the key global Opioids Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.
4.Provide market entry strategy analysis for new players or players preparing to enter the market
5.Keep up with international market trends and analyze the impact of the important international events on major global regions
6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape
-
With tables and figures helping analyze worldwide Global Opioids Drugs market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Opioids Drugs Market Research Report 2024, Forecast to 2029
1 Market Study Overview1.1 Study Objectives
1.2 Opioids Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary2.1 Opioids Drugs Segment by Type
2.1.1 Oxycodone
2.1.2 Hydromorphone
2.1.3 Codeine
2.1.4 Fentanyl
2.1.5 Other2.2 Market Analysis by Application
2.2.1 Pain Relief
2.2.2 Anesthesia
2.2.3 Other2.3 Global Opioids Drugs Market Comparison by Regions (2019-2029)
2.3.1 Global Opioids Drugs Market Size (2019-2029)
2.3.2 North America Opioids Drugs Status and Prospect (2019-2029)
2.3.3 Europe Opioids Drugs Status and Prospect (2019-2029)
2.3.4 China Opioids Drugs Status and Prospect (2019-2029)
2.3.5 Japan Opioids Drugs Status and Prospect (2019-2029)
2.3.6 Southeast Asia Opioids Drugs Status and Prospect (2019-2029)2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast2.5 Coronavirus Disease 2020 (Covid-19): Opioids Drugs Industry Impact
2.5.1 Opioids Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Opioids Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer3.1 Global Opioids Drugs Sales and Market Share by Manufacturer (2019-2024)
3.2 Global Opioids Drugs Revenue and Market Share by Manufacturer (2019-2024)
3.3 Global Opioids Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Opioids Drugs Manufacturer Market Share
3.5 Top 10 Opioids Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Opioids Drugs Market
3.7 Key Manufacturers Opioids Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Opioids Drugs Industry Key Manufacturers4.1 Purdue Pharma
4.1.1 Compan Detail
4.1.2 Purdue Pharma Opioids Drugs Product Introduction, Application and Specification
4.1.3 Purdue Pharma 162 Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.1.4 Main Business Overview
4.1.5 Purdue Pharma News4.2 J&J
4.2.1 Compan Detail
4.2.2 J&J Opioids Drugs Product Introduction, Application and Specification
4.2.3 J&J Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.2.4 Main Business Overview
4.2.5 Purdue Pharma News4.3 Teva
4.3.1 Compan Detail
4.3.2 Teva Opioids Drugs Product Introduction, Application and Specification
4.3.3 Teva Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.3.4 Main Business Overview
4.3.5 Teva News4.4 Mylan
4.4.1 Compan Detail
4.4.2 Mylan Opioids Drugs Product Introduction, Application and Specification
4.4.3 Mylan Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.4.4 Main Business Overview
4.4.5 Mylan News4.5 Depomed
4.5.1 Compan Detail
4.5.2 Mylan Opioids Drugs Product Introduction, Application and Specification
4.5.3 Depomed Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.5.4 Main Business Overview
4.5.5 Depomed News4.6 INSYS
4.6.1 Compan Detail
4.6.2 INSYS Opioids Drugs Product Introduction, Application and Specification
4.6.3 INSYS Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.6.4 Main Business Overview
4.6.5 INSYS News
4.7 Endo
4.7.1 Compan Detail
4.7.2 Endo Opioids Drugs Product Introduction, Application and Specification
4.7.3 Endo Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Pfizer
4.8.1 Compan Detail
4.8.2 Pfizer Opioids Drugs Product Introduction, Application and Specification
4.8.3 Pfizer Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.8.4 Main Business Overview
4.8.5 Pfizer News
4.9 Hikma
4.9.1 Compan Detail
4.9.2 Hikma Opioids Drugs Product Introduction, Application and Specification
4.9.3 Hikma Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.9.4 Main Business Overview
4.9.5 Hikma News4.10 Mallinckrodt
4.10.1 Compan Detail
4.10.2 Mallinckrodt Opioids Drugs Product Introduction, Application and Specification
4.10.3 Mallinckrodt Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.10.4 Main Business Overview
4.10.5 Mallinckrodt News
4.11 Pernix
4.11.1 Compan Detail
4.11.2 Pernix Opioids Drugs Product Introduction, Application and Specification
4.11.3 Pernix Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.11.4 Main Business Overview
4.11.5 Pernix News
4.12 Egalet
4.12.1 Compan Detail
4.12.2 Egalet Opioids Drugs Product Introduction, Application and Specification
4.12.3 Egalet Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.12.4 Main Business Overview
4.12.5 Egalet News
4.13 Vistapharm
4.13.1 Company Details
4.13.2 Vistapharm Opioids Drugs Product Introduction, Application and Specification
4.13.3 Vistapharm Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.13.4 Main Business Overview
4.13.5 Vistapharm News
5 Global Opioids Drugs Market Segment by Big Type5.1 Global Opioids Drugs Revenue, Sales and Market Share by Big Type (2019-2024)
5.1.1 Global Opioids Drugs Sales and Market Share by Big Type (2019-2024)
5.1.2 Global Opioids Drugs Revenue and Market Share by Big Type (2019-2024)5.2 Oxycodone Sales Growth Rate and Price
5.2.1 Global Oxycodone Sales Growth Rate (2019-2024)
5.2.2 Global Oxycodone Price (2019-2024)5.3 Hydromorphone Sales Growth Rate and Price
5.3.1 Global Hydromorphone Sales Growth Rate (2019-2024)
5.3.2 Global Hydromorphone Price (2019-2024)5.4 Codeine Sales Growth Rate and Price
5.4.1 Global Codeine Sales Growth Rate (2019-2024)
5.4.2 Global Codeine Price (2019-2024)5.5 Fentanyl Sales Growth Rate and Price
5.5.1 Global Fentanyl Sales Growth Rate (2019-2024)
5.5.2 Global Fentanyl Price (2019-2024)5.6 Other Sales Growth Rate and Price
5.6.1 Global Other Sales Growth Rate (2019-2024)
5.6.2 Global Other Price (2019-2024)
6 Global Opioids Drugs Market Segment by Big Application6.1 Global Opioids Drugs Sales Market Share by Big Application (2019-2024)
6.2 Pain Relief Sales Growth Rate (2019-2024)
6.3 Anesthesia Sales Growth Rate (2019-2024)
6.4 Other Sales Growth Rate (2019-2024)
7 Global Opioids Drugs Forecast7.1 Global Opioids Drugs Revenue, Sales and Growth Rate (2024-2029)
7.2 Opioids Drugs Market Forecast by Regions (2024-2029)
7.2.1 North America Opioids Drugs Market Forecast (2024-2029)
7.2.2 Europe Opioids Drugs Market Forecast (2024-2029)
7.2.3 China Opioids Drugs Market Forecast (2024-2029)
7.2.4 Japan Opioids Drugs Market Forecast (2024-2029)
7.2.5 Southeast Asia Opioids Drugs Market Forecast (2024-2029)
7.2.6 Other Regions Opioids Drugs Market Forecast (2024-2029)7.3 Opioids Drugs Market Forecast by Type (2024-2029)
7.3.1 Global Opioids Drugs Sales Forecast by Type (2024-2029)
7.3.2 Global Opioids Drugs Market Share Forecast by Type (2024-2029)7.4 Opioids Drugs Market Forecast by Application (2024-2029)
7.4.1 Global Opioids Drugs Sales Forecast by Application (2024-2029)
7.4.2 Global Opioids Drugs Market Share Forecast by Application (2024-2029)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Opioids Drugs Related Market Analysis9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Opioids Drugs Manufacturing Cost Analysis9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
-
The Global Opioids Drugs Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Global Opioids Drugs Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Depending upon the type of applications, the Global Opioids Drugs Market has been segmented into
During the projected year from 2024 to 2029, the Global Opioids Drugs Market is expected to grow at a CAGR of xx%.
The value of the Global Opioids Drugs Market is estimated to be USD XXX million.
The majority of data for the Global Opioids Drugs Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
